Xarelto 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FN1A3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,401
Award facts
- Contract value 100% obligated
- $17,400.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,400.54 to AmerisourceBergen Drug Corp for the supply of Xarelto 20 mg tablets (90-count units). This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by January 26, 2026. The contract represents a pharmaceutical supply delivery to support federal medical procurement needs, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds an expanded IDC with the Defense Logistics Agency valued up to $999,999,999.00 through December 31, 2031, enabling supply of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through open competition makes it a critical vendor for military and veteran healthcare systems, supplying medications across multiple therapeutic domains including specialty pharmaceuticals, vaccines, and medical devices.
Quick answers
Who was awarded contract SPE2DR26FN1A3?
SPE2DR26FN1A3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FN1A3 worth?
The government has obligated $17,401 on SPE2DR26FN1A3.
Is contract SPE2DR26FN1A3 an order under another contract?
Yes. SPE2DR26FN1A3 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1A3 competed?
The extent of competition for SPE2DR26FN1A3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award